Literature DB >> 2720975

Concentrations of lipids and apolipoproteins in patients with clinically well-controlled insulin-dependent and non-insulin-dependent diabetes.

J Joven1, E Vilella, B Costa, P R Turner, C Richart, L Masana.   

Abstract

The triglyceride and cholesterol content of total, very-low-, intermediate-, low-, and high-density lipoproteins, and of apolipoproteins (apo) Al, All, B, Cll, Clll, and E were determined in plasma from 107 patients with clinically well-controlled diabetes and from 66 age- and weight-matched healthy normal subjects. The diabetic patients were separated into two groups: those with insulin-dependent diabetes mellitus (IDDM, type 1, n = 24) and those with non-insulin-dependent diabetes mellitus (NIDDM, type 2, n = 83). The latter group contained two subgroups: those treated by diet (type 2d, n = 42) or by insulin (type 2i, n = 41). High-density lipoprotein cholesterol was increased in IDDM patients, and decreased in NIDDM patients relative to control subjects. Mean apo Al values in IDDM patients were higher than in their respective controls and in NIDDM patients. Concentrations of apo B, Clll, and E were higher in all diabetic patients than in the healthy controls, but those of apo Cll did not differ statistically between diabetics and nondiabetics. Although total plasma cholesterol and triglyceride concentrations were apparently near normal values in patients with good glycemic control, we found a persistent increase of intermediate-density lipoproteins (remnants) in all the diabetic groups studied. This factor may be related to the perceived increased cardiovascular risk in these individuals.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2720975

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

1.  The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients.

Authors:  R W James; D Pometta
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

Review 2.  Coronary heart disease in diabetes mellitus--antecedents and associations.

Authors:  P H Winocour
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

3.  Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients.

Authors:  J C Mazurkiewicz; G F Watts; F G Warburton; B M Slavin; C Lowy; E Koukkou
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

Review 4.  Atherogenic profiles in insulin-dependent diabetic patients and their treatment.

Authors:  I De Leeuw
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

5.  Apolipoprotein CIII promotes Ca2+-dependent beta cell death in type 1 diabetes.

Authors:  Lisa Juntti-Berggren; Essam Refai; Ioulia Appelskog; Mats Andersson; Gabriela Imreh; Nancy Dekki; Sabine Uhles; Lina Yu; William J Griffiths; Sergei Zaitsev; Ingo Leibiger; Shao-Nian Yang; Gunilla Olivecrona; Hans Jörnvall; Per-Olof Berggren
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

Review 6.  Apolipoprotein CIII Is an Important Piece in the Type-1 Diabetes Jigsaw Puzzle.

Authors:  Ismael Valladolid-Acebes; Per-Olof Berggren; Lisa Juntti-Berggren
Journal:  Int J Mol Sci       Date:  2021-01-19       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.